Use of Rimegepant in the Management of Cervicogenic Headache Secondary to Trauma: A Case Series

A cervicogenic headache (CH) originates from a cervical source. Multiple diagnostic criteria and treatment strategies for CH are present. Rimegepant is a calcitonin gene-related peptide receptor (CGRP) antagonist. We present a case series of three patients with CH who reported varying degrees of dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaw, Shin T, Zaw, Thinzar, Torres, Benito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Pain Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993035/
https://www.ncbi.nlm.nih.gov/pubmed/36909076
http://dx.doi.org/10.7759/cureus.34662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993035/
https://www.ncbi.nlm.nih.gov/pubmed/36909076
http://dx.doi.org/10.7759/cureus.34662

Ejemplares similares